Bendamustine Hydrochloride 83831-0183-04

Package NDC

83831-0183-04

Manufacturer: Avyxa Pharma, Llc
Dosage Form: Injection
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: May 29, 2026
Listing Expires: December 31, 2027
Application: NDA219014

Need to source Bendamustine Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Bendamustine Hydrochloride	100 mg/4mL

Drug Class

Alkylating Activity [MoA]Alkylating Drug [EPC]

Selected Package

83831-0183-04Selected

1 VIAL in 1 CARTON (83831-183-04) / 4 mL in 1 VIAL